To The Moon

Bullish Outlook on AMD: Seizing the AI Chip Throne Amid NVIDIA’s Rubin Setback In the high-stakes arena of AI hardware, Advanced Micro Devices (AMD) is emerging as a formidable contender, particularly with NVIDIA’s reported delay in launching its next-gen Rubin GPU. As of August 15, 2025, this development isn’t just a hiccup for NVIDIA—it’s a golden window for AMD to accelerate market share gains, bolstered by its upcoming MI450 accelerator. Here’s a bullish perspective: AMD isn’t merely catching up; it’s positioning itself as the cost-effective, innovative alternative in a market hungry for diversified AI solutions, potentially driving its stock to new heights by capitalizing on NVIDIA’s vulnerability and the explosive demand for data center GPUs. Why AMD’s MI450 Could Eclipse NVIDIA’s Do

1. $Celsius Holdings, Inc.(CELH)$ Hope you’re still in this Jared! +60% since that call out in May and +150% since smart money zone.Image2. $CoreWeave, Inc.(CRWV)$ Last chance support for CRWV or we’re going right into our discount zone. I’ll be a buyer at $60-$70Image3. $Lowe's(LOW)$ Bought around POC + IBZ. Still meets criteria, but with H&S forming + earnings ahead, I’m locking it in. Also cutting positions — 45 stocks is too many to manage well.Image4. $SoFi Technologies Inc.(SOFI)$ 02/20/26 $23 Calls – $1.38M Sweep (3,107 Contracts @ $4.45 Ask)I'm not chasing this setup as the time to buy was back in April when p

Citigroup Calls S&P 500 to 6,600 📈 — Are You Riding This Bull or Watching From the Sidelines? Wall Street just got a jolt of bullish energy. Citigroup has raised its year-end S&P 500 target to 6,600, up from 6,300 — signalling faith that this rally has more gas in the tank. At today’s ~6,250 level, that’s an implied upside of ~5.6% by year-end. In a year already packed with record highs, Citi is effectively telling investors: Don’t underestimate the bull. But with the index already up more than 20% YTD, is this the time to add risk — or start banking gains before the music stops? --- Why Citi Turned More Bullish 💡 Citi’s upgrade isn’t coming out of thin air. Their analysts point to three main drivers: Earnings resilience — Q2 results have largely beaten expectations, with mega-cap

I lean towards big-swing growth stocks like Sea when the fundamentals are strong. Q2 was impressive—Shopee’s GMV jumped 28% YoY, beating even bullish forecasts. Growth came from healthier order volumes, which feels more sustainable than just higher prices. SeaMoney’s 79% YoY revenue surge was another standout, showing fintech is becoming a key growth driver. Garena cooled after its Naruto boost, but that seems like a seasonal dip rather than a lasting weakness. Overall, Sea is firing on multiple cylinders despite margin pressures. The volatility is worth it for this kind of growth, though I still hold steady dividend payers like DBS for balance. If they can maintain this momentum, Sea could be one of the region’s top growth stories in the coming years.

When trading becomes a passion, it's time to step back a little.Lust for money becomes your main goal.You end up trading for the dopamine hit more than trying to make money. Investing should be slightly boring for me . If I get my emotions and feelings involved I tend to not make a good return. I used my Tiger account for my risky dopamine fuelled trades, and yes my Savings account had a better return in the long run. This year I am looking to do smaller, and more boring investments on Tiger Trade. Let's see how that will work. Happy Investing everyone . And yes that's me , in Las Vegas at the Binion Gambling Hall learning about all the deadly sins in investing.

Personally, I think $UnitedHealth(UNH)$ just got a credibility boost with Buffett stepping in. Berkshire doesn’t build positions on a whim—they usually see strong fundamentals, durable competitive advantages, and long-term growth potential. In the healthcare space, UNH is one of the giants with diversified revenue streams, which makes it appealing in both stable and volatile markets. That said, I’m not rushing to jump in right now. Healthcare stocks can be sensitive to policy changes, cost pressures, and earnings surprises. My plan is to monitor UNH closely for a better entry point rather than chasing it on the news. For now, I’ll keep it on my watchlist and track both technical and fundamental developments. If the momentum continues and the ris

$UnitedHealth(UNH)$ Warren Buffett’s Berkshire Hathaway dropped a bombshell with its Q2 2025 13F filing today, August 15, 2025, unveiling a bold new stake in UnitedHealth Group (UNH). The investment giant snapped up 5.039 million shares of the U.S. health insurance titan for approximately $1.6 billion, with an average purchase price of $314 per share. By quarter’s end, the position was valued at $1.57 billion, securing its spot as the 18th largest holding in Berkshire’s $300 billion portfolio, trailing Amazon and Constellation Brands (STZ). With the S&P 500 at 6,466.58, Nasdaq at 21,713.14, and Bitcoin surging to $124,002, the market pulses with optimism, though tariffs (30% on EU/Mexico, 35% on Canada) and oil at $75/barrel cast shadows. Is th

Citron Research’s Andrew Left has reignited the short-selling spotlight, declaring Palantir Technologies ( $Palantir Technologies Inc.(PLTR)$ ) a target with a bold claim that its stock must drop to $40-$50—implying a 70% plunge from its current $134.20—to be considered “truly cheap.” Announced during a Wednesday interview, this move follows Citron’s infamous clash with GameStop’s (GME) short squeeze in 2021, where it faced a retail investor backlash. Now, the firm sets its sights on Palantir, branding it an “overvalued retail darling” with a market cap of $297 billion as of Friday, August 15, 2025. Against a backdrop of the S&P 500 at 6,466.58, Nasdaq at 21,713.14, and Bitcoin at $124,002, the market hums with energy, though tariffs (30% on E

$S&P 500(.SPX)$ $NASDAQ(.IXIC)$ The market is buzzing on August 15, 2025, as investors digest a wave of fresh developments that could shape today’s trading. With the S&P 500 at 6,466.58, Nasdaq at 21,713.14, and Bitcoin climbing to $124,002, the bullish momentum holds strong, fueled by robust domestic inflows and a rebound in tech. However, tariffs (30% on EU/Mexico, 35% on Canada) and oil at $75/barrel keep volatility in check, with the VIX at 14.49. Berkshire Hathaway’s $1.6 billion bet on UnitedHealth (UNH) via its Q2 13F filing has sparked a 7% after-hours surge to $268, while Citron Research’s short on Palantir (PLTR) at $134.20, targeting $40-$50, stirs a retail vs. bear showdown. Add India

$Ingersoll Rand Inc.(IR)$ Ingersoll Rand’s (NYSE: IR) share price plunged in the immediate aftermath of its second-quarter 2025 results, wiping out double-digit equity value even as the company reported record orders, revenue growth and improved adjusted EBITDA. The disconnect between headline operational momentum and investor reaction reflects a market that is increasingly focused on quality of earnings, organic growth trends, and the details buried in GAAP versus adjusted results. This article unpacks the quarter line by line, explains what likely triggered the sell-off, and lays out a clear verdict — including an entry-price zone for long-term, risk-aware investors. Quarter at a glance — record orders and revenue, but an ugly GAAP line Ingersoll

A single day pre market run with UNH holding..  See you in the mood soon 💘...